Estados Unidos · Agencias y tiempo real · PR Newswire

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Publicado por PR Newswire · Estados Unidos hace 1 h

BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing…

Leer el artículo completo en PR Newswire Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.prnewswire.com)

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

También te puede interesar

What to consider if a company that made AI-related job cuts wants you back

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Compartir

También te puede interesar

What to consider if a company that made AI-related job cuts wants you back

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows